Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso
Last updated 02 novembro 2024
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Anti-IL-17A treatment reduces serum inflammatory, angiogenic and
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
IJMS, Free Full-Text
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Evaluation of BASDAI (Panel A) and ASDAS-CRP (Panel B) during
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Therapeutic potential of TNFα inhibitors in chronic inflammatory
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
IJMS, Free Full-Text
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Long noncoding RNA intersectin 1-2 gradually declines during
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Recommendations by the Spanish Society of Rheumatology on the Use
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Effects of tapering tumor necrosis factor inhibitor on the
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Maintained activity in ankylosing spondylitis patients treated with
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Effects of ustekinumab on spondylitis-associated endpoints in TNFi
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
The BASDAI Cut-Off for Disease Activity Corresponding to - Frontiers
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
JCM, Free Full-Text
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Response to TNF-α-inhibitor (TNFi) treatment as assessed by the

© 2014-2024 empresaytrabajo.coop. All rights reserved.